Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor
Open accessAbstract
Background Activity-dependent release of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC) is essential for the rapid and sustained antidepressant actions of ketamine, and a recent study shows a similar requirement for vascular endothelial growth factor (VEGF). Since BDNF is reported to stimulate VEGF expression and/or release in neuroblastoma cells, the present study tested the hypothesis that the actions of BDNF are mediated by VEGF.Methods The role of VEGF in the antidepressant behavioral actions of BDNF was tested by intra-mPFC coinfusion of a VEGF neutralizing antibody and by neuron-specific deletion of VEGF. The influence of BDNF on the release of VEGF and the role of VEGF in the neurotrophic actions of BDNF were determined in rat primary cortical neurons. The role of BDNF in the behavioral and neurotrophic actions of VEGF was also determined.Results The results show that the rapid and sustained antidepressant-like actions of intra-mPFC BDNF are blocked by coinfusion of a VEGF neutralizing antibody, and that neuron-specific mPFC deletion of VEGF blocks the antidepressant-like actions of BDNF. Studies in primary cortical neurons demonstrate that BDNF stimulates the release of VEGF and that BDNF induction of dendrite complexity is blocked by a selective VEGF-fetal liver kinase 1 receptor antagonist. Surprisingly, the results also show reciprocal interactions, indicating that the behavioral and neurotrophic actions of VEGF are dependent on BDNF.Conclusions These findings indicate that the antidepressant-like and neurotrophic actions of BDNF require VEGF signaling, but they also demonstrate reciprocal interdependence for BDNF in the actions of VEGF.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
mTORC1 activation is driven by BDNF signaling and might enhance BDNF production, creating a positive feedback loop that sustains neuroplasticity.
“mTORC1 activation appears to be driven by BDNF signaling, and in turn, mTORC1 itself might enhance BDNF production, creating a positive feedback loop that sustains neuroplasticity [75,76].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [75]
The Discussion (page unavailable) cites evidence that BDNF stimulates VEGF expression and release through an mTORC1 pathway. The Results and Discussion describe reciprocal BDNF–VEGF signaling, but do not say that mTORC1 enhances BDNF production or establishes the claimed mTORC1–BDNF feedback loop. (LLM, conf=0.84)
Experimental — accuracy not yet measuredA single infusion of recombinant BDNF into the mPFC produces rapid and sustained antidepressant effects similar to those observed with ketamine administration.
“a single infusion of recombinant BDNF into the mPFC produces rapid and sustained antidepressant effects similar to those observed with ketamine administration [75,76]”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796 · see citing works
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · see citing works
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,373 · see citing works
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,012 · see citing works
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
Self-citationmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works
Self-citationSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · see citing works
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works
Self-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · see citing works
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · see citing works
Self-citationNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779 · see citing works
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · see citing works
Self-citationBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · see citing works
Self-citationRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · see citing works
Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus
Kang, H., & Schuman, E. M. (1995) · Science · doi:10.1126/science.7886457 · Cited by 1,354 · see citing works
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340 · see citing works
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206 · see citing works
Self-citationLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · see citing works
Self-citationVEGF is required for growth and survival in neonatal mice
Gerber, H., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L. K., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 913 · see citing works
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800 · see citing works
Neurotrophic factors: from molecule to man
Lindsay, R. M., Wiegand, S. J., Altar, C. A., & DiStefano, P. S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90099-x · Cited by 789 · see citing works
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · see citing works
Wise, T., Radua, J., Via, E., Cardoner, N., Abe, O., Adams, T. M., Amico, F., Cheng, Y., Cole, J. H., de Azevedo Marques Périco, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.72 · Cited by 606 · see citing works
Karege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600 · see citing works
Eide, F. F., Vining, E. R., Eide, B. L., Zang, K., Wang, X., & Reichardt, L. F. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03123.1996 · Cited by 473 · see citing works
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438 · see citing works
Self-citationLiu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S., & Aghajanian, G. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.030 · Cited by 403 · see citing works
Self-citationBDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368 · see citing works
Self-citationNeurobiology of local and intercellular BDNF signaling
Sasi, M., Vignoli, B., Canossa, M., & Blum, R. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1964-4 · Cited by 324 · see citing works
Li, Y., Zhang, Y., Lester, H. A., Schuman, E. M., & Davidson, N. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10231.1998 · Cited by 318 · see citing works
Yu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275 · see citing works
Voleti, B., Navarria, A., Liu, R.-J., Banasr, M., Li, N., Terwilliger, R., Sanacora, G., Eid, T., Aghajanian, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.025 · Cited by 264 · see citing works
Self-citationHeine, V. M., Zareno, J., Maslam, S., Joëls, M., & Lucassen, P. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03951.x · Cited by 225 · see citing works
Rosenstein, J. M., Mani, N., Khaibullina, A., & Krum, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11036.2003 · Cited by 220 · see citing works
Nakamura, K., Martin, K. C., Jackson, J. K., Beppu, K., Woo, C., & Thiele, C. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2789 · Cited by 219 · see citing works
Carmignoto, G., Pizzorusso, T., Tia, S., & Vicini, S. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021848 · Cited by 219 · see citing works
Laje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.031 · Cited by 213 · see citing works
Truncated TrkB: Beyond a dominant negative receptor
Fenner, B. M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.01.002 · Cited by 212 · see citing works
Su, T., Chen, M., Li, C., Lin, W.-C., Hong, C., Gueorguieva, R. V., Tu, P., Bai, Y., Cheng, C., & Krystal, J. H. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.94 · Cited by 208 · see citing works
The Female Urine Sniffing Test: A Novel Approach for Assessing Reward-Seeking Behavior in Rodents
Malkesman, O., Scattoni, M. L., Paredes, D., Tragon, T. R., Pearson, B. L., Shaltiel, G., Chen, G., Crawley, J. N., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.018 · Cited by 197 · see citing works
Lepack, A. E., Bang, E., Lee, B., Dwyer, J. M., & Duman, R. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.011 · Cited by 174 · see citing works
Self-citationLeßmann, V., & Heumann, R. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00035-9 · Cited by 162 · see citing works
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157 · see citing works
Greene, J., Banasr, M., Lee, B., Warner-Schmidt, J., & Duman, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.68 · Cited by 143 · see citing works
Self-citationGhosal, S., Bang, E., Yue, W., Hare, B. D., Lepack, A. E., Girgenti, M. J., & Duman, R. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.017 · Cited by 111 · see citing works
Self-citationLiu, R.-J., Duman, C., Kato, T., Hare, B., Lopresto, D., Bang, E., Burgdorf, J., Moskal, J., Taylor, J., Aghajanian, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.202 · Cited by 105 · see citing works
Self-citationKim, B. W., Choi, M. L., Kim, Y.-S., Park, H., Lee, H., Yun, C., Kim, E. J., Choi, J.-S., Kim, S., Rhim, H., et al. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.009 · Cited by 104 · see citing works
Deyama, S., Bang, E., Wohleb, E. S., Li, X., KATO, T., Gerhard, D. M., Dutheil, S., Dwyer, J. M., Taylor, S. R., Picciotto, M. R., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17121368 · Cited by 99 · see citing works
Self-citationIsung, J., Aeinehband, S., Mobarrez, F., Mårtensson, B., Nordström, P., Åsberg, M., Piehl, F., & Jokinen, J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.123 · Cited by 98 · see citing works
A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior
Rossi, P. D., Harde, E., Dupuis, J. P., Martin, L., Chounlamountri, N., Bardin, M., Watrin, C., Benetollo, C., Pernet‐Gallay, K., Luhmann, H. J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.195 · Cited by 92 · see citing works
BDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13
Kato, T., Fogaça, M. V., Deyama, S., Li, X.-Y., Fukumoto, K., & Duman, R. S. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.220 · Cited by 88 · see citing works
Self-citationAbnormal Retinoid and TrkB Signaling in the Prefrontal Cortex in Mood Disorders
Qi, X., Zhao, J. Y., Liu, J., Fang, H., Swaab, D. F., & Zhou, J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht203 · Cited by 78 · see citing works
Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior
Dwyer, J. M., Maldonado-Avilés, J. G., Lepack, A. E., DiLeone, R. J., & Duman, R. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505289112 · Cited by 76 · see citing works
Self-citationLong-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex
Howell, K. R., Kutiyanawalla, A., & Pillai, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020198 · Cited by 75 · see citing works
Differential brain, but not serum VEGF levels in a genetic rat model of depression
Elfving, B., Plougmann, P. H., & Wegener, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.063 · Cited by 61 · see citing works
Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons
Xiong, H., Futamura, T., Jourdi, H., Zhou, H., Takei, N., Diversé-Pierluissi, M. A., Plevy, S. E., & Nawa, H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00043-6 · Cited by 56 · see citing works
Choi, M., Lee, S. H., Chang, H. L., & Son, H. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.001 · Cited by 37 · see citing works
Brain-derived neurotrophic factor in the infralimbic cortex alleviates inflammatory pain
Yue, L., Ma, L., Cui, S., Liu, F., Yi, M., & Wan, Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.028 · Cited by 30 · see citing works
Calcium-Dependent and Synapsin-Dependent Pathways for the Presynaptic Actions of BDNF
Cheng, Q., Song, S., & Augustine, G. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00075 · Cited by 29 · see citing works
Yang, J.-J., Yang, C., Liu, C., Zhang, T., & Yang, Z. (2016) · Hippocampus · doi:10.1002/hipo.22544 · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [22]Qi XR, Zhao J, Liu J, Fang H, Swaab DF, Zhou JN (2015): Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders. Cereb Cortex 25: 75– 83. 23960204
Cited by
Sorted by citations
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540 · see citing works
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335 · see citing works
Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321 · see citing works
Self-citationNeurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186 · see citing works
Self-citationNeurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 156 · see citing works
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Hanson, J. E., Yuan, H., Perszyk, R. E., Banke, T. G., Xing, H., Tsai, M., Menniti, F. S., & Traynelis, S. F. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01614-3 · Cited by 116 · see citing works
Li, G., Zhao, M., Cheng, X., Zhao, T., Feng, Z., Zhao, Y., Fan, M., & Zhu, L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00807-3 · Cited by 82 · see citing works
Kang, M. J. Y., Hawken, E., & Vazquez, G. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.860882 · Cited by 77 · see citing works
Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities
Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54 · see citing works
Dattilo, V., Amato, R., Perrotti, N., & Gennarelli, M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00826 · Cited by 49 · see citing works
Brain stimulation effects on serum BDNF, VEGF, and TNFα in treatment‐resistant psychiatric disorders
Valiulienė, G., Valiulis, V., Dapšys, K., Vitkevičienė, A., Gerulskis, G., Navakauskienė, R., & Germanavičius, A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15232 · Cited by 49 · see citing works
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51 · see citing works
Deyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 46 · see citing works
Self-citationHan, H., Yao, J., Wu, J., Mao, S., Pan, H., Qv, L., Zhu, G., Ren, J., Yu, Y., Xuan, F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03044-7 · Cited by 46 · see citing works
Rejdak, K., Sienkiewicz‐Jarosz, H., Bieńkowski, P., & Álvarez, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21960 · Cited by 43 · see citing works
He, Y., Li, W., Wang, Y., Tian, Y., Chen, X., Wu, Z., Lan, T., Li, Y., Bai, M., Liu, J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.131 · Cited by 44 · see citing works
Deyama, S., Kondo, M., Shimada, S., & Kaneda, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01943-9 · Cited by 43 · see citing works
Self-citationAntidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41 · see citing works
Chaperone Sigma1R and Antidepressant Effect
Воронин, М. В., Vakhitova, Y. V., & Середенин, С. Б. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197088 · Cited by 40 · see citing works
Khalil, M. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312924 · Cited by 44 · see citing works
Lu, X., Liu, H., Cai, Z., Hu, Z., Ye, M., Gu, Y., Wang, Y., Wang, D., Lu, Q., Shen, Z., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.005 · Cited by 38 · see citing works
Hashimoto, K., Zhao, M., Zhu, T., Wang, X., & Yang, J. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.07.001 · Cited by 38 · see citing works
Li, W.-Y., Zhu, Q., Jin, L.-Y., Yang, Y., Xu, X.-Y., & Hu, X.-Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308665 · Cited by 37 · see citing works
Elia, A., Cannavò, A., Gambino, G., Cimini, M., Ferrara, N., Kishore, R., Paolocci, N., & Rengo, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.07.009 · Cited by 31 · see citing works
Müller, L., & Benedetto, S. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00341-z · Cited by 31 · see citing works
Pu, J., Liu, Y., Gui, S., Tian, L., Xu, S., Song, X., Zhong, X., Chen, Y., Chen, X., Yu, Y., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113319 · Cited by 30 · see citing works
Tang, Y., Su, H., Wang, H., Lu, F., Nie, K., Wang, Z., Huang, W., & Dong, H. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00414-z · Cited by 30 · see citing works
The Antidepressant-Like Effects of Shen Yuan in a Chronic Unpredictable Mild Stress Rat Model
Jiang, N., Wang, H., Huang, H. M., Lv, J., Zeng, G., Wang, Q., Bao, Y., Chen, Y., & Liu, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.622204 · Cited by 28 · see citing works
Astrocyte-derived lactate in stress disorders
Chamaa, F., Magistretti, P. J., & Fiumelli, H. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106417 · Cited by 29 · see citing works
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Borsellino, P., Krider, R. I., Chea, D., Grinnell, R., & Vida, T. A. (2023) · Pharmaceuticals · doi:10.3390/ph16050742 · Cited by 22 · see citing works
Ma, H., Li, J., Qiao, X., Zhang, Y., Hou, X.-J., Chen, H., Chen, H., Zhang, Y., & Li, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01201-8 · Cited by 28 · see citing works
Kranaster, L., Blennow, K., Zetterberg, H., & Sartorius, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.080 · Cited by 25 · see citing works
Medeiros, G. C., Greenstein, D., Kadriu, B., Yuan, P., Park, L. T., Gould, T. D., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.011 · Cited by 24 · see citing works
Joshi, R., & Salton, S. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.932497 · Cited by 24 · see citing works
Ren, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110910 · Cited by 23 · see citing works
Castillo, M. F. R., Cohen, A. J., Edberg, D., Hoppensteadt, D., Fareed, J., Martin, B., & Halaris, A. E. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112781 · Cited by 23 · see citing works
Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression
Zhou, X., Bao, W.-D., Liu, D., & Zhu, L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191101124017 · Cited by 22 · see citing works
Haleem, E. N. A. A., Ahmed, H. I., & El‐Naga, R. N. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1988797 · Cited by 21 · see citing works
The interplay of neurovasculature and adult hippocampal neurogenesis
Kim, T. A., Chen, L., & Ge, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136071 · Cited by 20 · see citing works
Deyama, S., Aoki, S., Sugie, R., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01337-1 · Cited by 18 · see citing works
Self-citationCurcumin attenuates brain aging by reducing apoptosis and oxidative stress
Cheriki, M., Habibian, M., & Moosavi, S. J. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-023-01326-z · Cited by 18 · see citing works
Deyama, S., & Kaneda, K. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112844 · Cited by 18 · see citing works
Self-citationResolvins as potential candidates for the treatment of major depressive disorder
Deyama, S., Minami, M., & Kaneda, K. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.002 · Cited by 18 · see citing works
Self-citationResolution of depression: Antidepressant actions of resolvins
Deyama, S., Kaneda, K., & Minami, M. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.10.006 · Cited by 17 · see citing works
Self-citationNeuron-specific deletion of VEGF or its receptor Flk-1 impairs recognition memory
Deyama, S., Li, X., & Duman, R. S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.11.002 · Cited by 17 · see citing works
Self-citationThe Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Fígaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., Baes, C. V. W., Coeli‐Lacchini, F. B., Tanus-Santos, J. E., Juruena, M. F., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122757 · Cited by 17 · see citing works
Involvement of muscarinic receptor mechanisms in antidepressant drug action
Witkin, J. M., Smith, J. L., Golani, L. K., Brooks, E. A., & Martin, A. E. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.003 · Cited by 16 · see citing works
Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels
Robinson, B. L., Gu, Q., & Kanungo, J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00411 · Cited by 16 · see citing works
Zhang, L., Liu, X., Li, T., Xu, B., & Fu, B. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s334647 · Cited by 16 · see citing works
Vascular endothelial growth factor: a key factor in the onset and treatment of depression
Wang, J., Meng, F., Wang, L., & Li, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1645437 · Cited by 15 · see citing works
Николаевна, Н. И., Greco, V., Sciuto, S., Attanasio, F., & Rizzarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413504 · Cited by 15 · see citing works
Tsai, S., Kao, C.-F., Su, T., Li, C., Lin, W., Hong, C., Bai, Y., Tu, P., & Chen, M. (2023) · CNS Drugs · doi:10.1007/s40263-023-00989-7 · Cited by 15 · see citing works
Bränn, E., Skalkidou, A., Schwarz, J. M., Papadopoulos, F. C., Poromaa, I. S., & Fransson, E. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100468 · Cited by 14 · see citing works
The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice
Aoki, S., Deyama, S., Sugie, R., Ishimura, K., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113676 · Cited by 14 · see citing works
Self-citationSerum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13 · see citing works
Zhang, Y., Pan, Y., Zheng, W.-Y., Li, H.-Y., Zhu, M., yang, W.-J. O., Qian, Y., Turecki, G., Mechawar, N., & Zhu, X. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103005 · Cited by 13 · see citing works
The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
Markov, D. D., Dolotov, O. V., & Grivennikov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076664 · Cited by 14 · see citing works
Zheng, W., Gu, L.-M., Zhou, Y.-L., Wang, C.-Y., Lan, X.-F., Zhang, B., Shi, H.-S., Wang, D.-F., & Ning, Y.-P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.780975 · Cited by 12 · see citing works
Chitin conduits modified with DNA-peptide coating promote the peripheral nerve regeneration
Liu, S., Zhou, L., Li, C., Min, T., Lu, C., Han, S., Zhang, M., Wen, Y., Zhang, P., & Jiang, B. (2021) · Biofabrication · doi:10.1088/1758-5090/ac3bdc · Cited by 12 · see citing works
Can, A., Mitchell, J., Dutton, M., Bennett, M. R., Hermens, D. F., & Lagopoulos, J. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13572 · Cited by 11 · see citing works
Wang, Z., Hu, X., Wang, Z., Chen, J., Wang, L., Li, C., Deng, J., Yue, K., Wang, L., Kong, Y., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.019 · Cited by 10 · see citing works
Zheng, W., Zhou, Y., Wang, C., Lan, X., Zhang, B., Zhou, S., Yan, S., Yang, M., Nie, S., & Ning, Y. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211014320 · Cited by 10 · see citing works
Deyama, S., Sugie, R., Tabata, M., & Kaneda, K. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2254542 · Cited by 9 · see citing works
Self-citationLi, C., Zhang, J., Liu, H., Yuan, H., Cai, J., Fogaça, M. V., & Zhang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115137 · Cited by 8 · see citing works
Chen, M., Lin, W., Li, C., Wu, H.-J., Bai, Y., Tsai, S., Su, T., & Tu, P. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.022 · Cited by 8 · see citing works
Matsuzaka, Y., & Yashiro, R. (2025) · Biologics · doi:10.3390/biologics5010007 · Cited by 8 · see citing works
A rat study model of depression‐driven chronic prostatitis by modulating the PI3K /Akt/ mTOR network
Feng, J., Hou, D., Zhao, C., Bao, B., Huang, S., Deng, S., Meng, F., Zhao, Q., Wang, B., Li, H., et al. (2022) · Andrologia · doi:10.1111/and.14488 · Cited by 8 · see citing works
Faraji, J., & Metz, G. A. S. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.73 · Cited by 8 · see citing works
The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
Park, D., Lee, G., Lee, W.-G., Kim, B. S., Lee, Y., & Kim, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03100-2 · Cited by 9 · see citing works
Zheng, W., Gu, L.-M., Zhou, Y., Wang, C., Lan, X., Zhang, B., & Ning, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.855995 · Cited by 7 · see citing works
Maurer, J., Yanez, A., Bengtson, C. P., Bading, H., Draguhn, A., Mauceri, D., & Both, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.012 · Cited by 7 · see citing works
Zhang, Y., Li, X., Wang, X., Wang, X., Li, G., Xue, Q.-Y., Zhang, M., & Ao, H. (2023) · Pharmaceuticals · doi:10.3390/ph16111607 · Cited by 6 · see citing works
Self-citationThe impact of chronic pain on brain gene expression
Collier, L., Seah, C., Hicks, E. M., Holtzheimer, P. E., Krystal, J. H., Girgenti, M. J., Huckins, L. M., & Johnston, K. J. A. (2025) · Pain · doi:10.1097/j.pain.0000000000003707 · Cited by 6 · see citing works
Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19
Razi, O., Tartibian, B., Laher, I., Govindasamy, K., Zamani, N., Rocha‐Rodrigues, S., Suzuki, K., & Zouhal, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.783251 · Cited by 6 · see citing works
Deyama, S., Li, X., & Duman, R. S. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12393 · Cited by 5 · see citing works
Self-citationHan, X., Wu, Y., Zhong, Y., & Becker, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00736 · Cited by 5 · see citing works
Resolvins as novel targets for rapid-acting antidepressants
Deyama, S. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20044 · Cited by 5 · see citing works
Self-citationMarkiewicz, R., Markiewicz-Gospodarek, A., Dobrowolska, B. B., Bojar, I., & Łoza, B. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/163327 · Cited by 4 · see citing works
Quigley, B. L., Wellington, N. J., Levenstein, J. M., Dutton, M., Bouças, A. P., Forsyth, G., Gallay, C. C., Hajishafiee, M., Treacy, C., Lagopoulos, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91840-0 · Cited by 4 · see citing works
Liu, Y., Zou, L., Wang, P., Zhou, J., Yuan, C., & Wang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9794 · Cited by 4 · see citing works
Antidepressant-like effects of trophic factor receptor signaling
Sathyanesan, M., & Newton, S. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.958797 · Cited by 3 · see citing works
Ahtiainen, A., Genocchi, B., Subramaniyam, N. P., Tanskanen, J. M. A., Rantamäki, T., & Hyttinen, J. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16182 · Cited by 3 · see citing works
Chu, H., Sun, N., Tang, Q., Yu, X. L., Li, L., & Hong-sheng, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119960 · Cited by 3 · see citing works
Xu, Q., Liang, R., Gao, J., Fan, Y., Dong, J., Wang, L., Zheng, C., Yang, J., & Ming, D. (2024) · Life Sciences in Space Research · doi:10.1016/j.lssr.2024.04.001 · Cited by 3 · see citing works
Zhang, S., Chen, Q., Wu, L., Sun, K., Lan, X., Xie, X., & Yan, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5750647 · Cited by 3 · see citing works
RetractedLiu, C., Hu, W., Feng, X., & Qu, F. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.10.003 · Cited by 2 · see citing works
Galanin, I. V., Нарышкин, А. Г., Ляскина, И. Ю., & Александрович, С. Т. (2022) · Human Physiology · doi:10.1134/s0362119722020062 · Cited by 2 · see citing works
Reese, S. E., Conradt, E. D., Riquino, M. R., & Garland, E. L. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.688359 · Cited by 2 · see citing works
Deyama, S., Mishiro, K., Kunishima, M., & Kaneda, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178301 · Cited by 1 · see citing works
Self-citationНиколаевна, Н. И., & Rizzarelli, E. (2025) · Antioxidants · doi:10.3390/antiox14121512 · Cited by 1 · see citing works
Quigley, B. L., Orr, E., Kafka, S., Hajishafiee, M., Bouças, A. P., Wellington, N. J., Dutton, M., Jones, M., Randall, F., Lagopoulos, J., et al. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07043-6 · Cited by 1 · see citing works
Xue, L., Pan, Z., Liu, Y., Gan, Q., Liu, D., & Liu, D. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111856 · Cited by 1 · see citing works
Perineural invasion: A neuroimmune axis mediating immunotherapy resistance across malignancies
Guo, J., Hu, Z., Wu, L., Liu, L., Li, Z., Xiong, L., & Yu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116636 · Cited by 1 · see citing works
Chapter 14. Citalopram and Escitalopram
Shelton, R. C. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as14 · Cited by 1 · see citing works
Deyama, S. (2023) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.23-00111 · Cited by 1 · see citing works
Self-citationNeuron-Glia Signaling Regulates the Onset of the Antidepressant ResponsePreprint
Yao, V., Aly, A., Kalik, S., Gresack, J. E., Wang, W., Handler, A., Schaefer, A., Troyanskaya, O. G., Greengard, P., & Chottekalapanda, R. U. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453443 · Cited by 1 · see citing works
Habibian, M., & Moosavi, S. J. (2023) · Preprints.org · doi:10.20944/preprints202302.0290.v1 · Cited by 1 · see citing works
The neurobiology of treatment-resistant depression
Shelton, R. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00004-9
Lima‐Ojeda, J. M., & Ċastrén, E. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.003
Lin, E., Kuo, P.-H., Liu, Y.-L., Yang, A., & Tsai, S.-J. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_30_19
- Authors
- Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S.
- Affiliations
- Kanazawa University (JP)
- Yale University (US)
- Sumitomo Dainippon Pharma (Japan) (JP)
- Corresponding author
- Duman, Ronald S.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 86
- Issue
- 2
- Pages
- 143-152
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC6597338
- OpenAlex
- W2907856418
- Cited by
- 116
- References
- 66
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 12 · 2023: 22 · 2022: 17 · 2021: 20 · 2020: 14 · 2019: 10
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH045481, MH093897)
- State of Connecticut
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, vascular endothelial growth factor, antidepressant effects, ketamine, medial prefrontal cortex, VEGF neutralizing antibody, neurotrophic signaling
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Cerebral Cortex, Male, Mice, Inbred C57BL, Microinjections, Neurons, Gene Deletion, Prefrontal Cortex, Nootropic Agents, Antibodies, Blocking, Brain-Derived Neurotrophic Factor, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Mice, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review